Prevalence of chronic obstructive pulmonary disease among patients with systemic arterial hypertension without respiratory symptoms
Carregando...
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Background: The diagnosis of chronic obstructive pulmonary disease (COPD) is often delayed
until later stages of the disease. The purpose of the present study was to determine the prevalence
of COPD among adults on treatment for systemic arterial hypertension independently of the
presence of respiratory symptoms.
Methods: This cross-sectional study included adults aged $40 years with tobacco/occupational
exposure and systemic arterial hypertension diagnosed at three Primary Health Care facilities
in Goiania, Brazil. Patients were evaluated using a standardized respiratory questionnaire and
spirometry. COPD prevalence was measured considering the value of forced vital capacity and/
or forced expiratory volume in 1 second ,0.70.
Results: Of a total of 570 subjects, 316 (55%) met inclusion criteria and were invited to participate.
Two hundred and thirty-three (73.7%) patients with arterial hypertension reported at least one
respiratory symptom, while 83 (26.3%) reported no respiratory symptoms; 41 (17.6%) patients
with arterial hypertension and at least one respiratory symptom, and 10 (12%) patients with arterial
hypertension but no respiratory symptoms were diagnosed with COPD (P=0.24). The prevalence
of COPD in people with no previous COPD diagnosis was greater among those with no respiratory
symptoms (100%) than among those with respiratory symptoms (56.1%) (P=0.01).
Conclusion: Our findings suggest that regardless of the presence of respiratory symptoms,
individuals aged $40 years with tobacco/occupational exposure and arterial hypertension may
benefit from spirometric evaluation.
Descrição
Palavras-chave
Citação
RABAHI, Marcelo Foaud et al. Prevalence of chronic obstructive pulmonary disease among patients with systemic arterial hypertension without respiratory symptoms. International Journal of Chronic Obstructive Pulmonary Disease, London, v. 10, p. 1525-1529, 2015.